Higher demand and rising prices likely to help firms like UPL and PI offset input cost pressure
Most brokerages are positive on the long term prospects of the stock
Semiconductor shortage and execution delays, however, dented its FY22 performance
Margin performance will be an additional trigger going ahead
The extent of the raw material risk is more for tyres as compared to others given the dependence on the crude oil derivatives.
Double-digit growth and improving profitability to drive earnings in FY23
While there are multiple positives across SRF's key segments, investors should await for a better opportunity to enter the stock
Cash deployment and valuation upside for new business/investee firms are other triggers
Both residential and leasing trends point to strong showing in FY23
A YoY fall in volumes in the March quarter would be a first in seven quarters
Though the stock has gained 35% over the past month, given that target prices of brokerages range between Rs 410-Rs 450 a share, there is still an upside of over 37% likely from the current levels
While pricing action is expected, margins may remain under pressure for Voltas.
Rerating on the cards; the domestic business is expected to outperform
The stock remains one of the top picks among brokerages in the mid-cap IT space
While earnings estimates are cut, analysts hint at volume and margin recovery
Turnaround hopes and attractive valuations, however, keep the Street positive on the stock
Distribution yields could go up but risk of covid infection, interest rates remain
Progress on US sales will be key for further Torrent Pharma's stock gains
Lower copra costs and price cuts to aid volumes and margins
Inability to pass on the entire cost will squeeze margins